The College of Medicine, CME along with Continuing Professional Development for Pharmacy Professionals (CPDPP) are launching a new program called Advancing Interprofessional Management of Substance Use Disorders in Saskatchewan ( AIMS-SK).  The AIMS-SK program is designed to improve health outcomes for individuals with substance use disorders.   

Target Audience:

The target audience is Physicians, Pharmacists, Nurse Practitioners, Nurses, Dentists, Social Workers, Addiction Counsellors, and other health care professionals are encouraged to attend.

Full Program Learning Objectives:

At the end of this program, participants will be able to:

1. Describe the foundational principles and importance of harm reduction for people living with a substance use disorder (SUD).
2. Effectively support people with a SUD in the participant’s care setting.
3. Recognize appropriate opioid prescribing and dispensing.
4. Identify healthcare provider supports available when supporting people with a SUD.

 

Module 2 | Opioid Use Disorder 

Friday June 3rd 
Time: 8:00 am - 3:00 pm
Platform: Zoom

Module 2 Learning Objectives:

At the end of this module, participants will be able to:

1. Summarize the ‘College of Physicians and Surgeons of Saskatchewan Opioid Agonist Therapy Program Standards and Guidelines’ including educational requirements and program restrictions.
2. Outline the ‘Saskatchewan Registered Nurses Association Nurse Practitioner Controlled Drugs and Substances Prescribing Guidelines’ for prescribing opioid use disorder medications.
3. Properly assess patients with opioid use disorder.
4. Differentiate between different opioid agonist therapies, including prescribing requirements and the different approaches to initiation.
5. Appropriately use drug screening to optimize treatment for patients.
6. Compare the pros and cons of opioid agonist therapy carries.
7. Understand the role of the pharmacist in opioid agonist therapy.
8. Describe the use of opioid agonist therapy in pregnancy and breastfeeding.
9. Summarize lessons learned from experienced opioid agonist therapy prescribers.

 

Review timeline, topics, speakers & session specific learning objectives. Schedule is subject to change.

 

• Agenda

Module 2 Accreditation Statement

Royal College of Physicians and Surgeons of Canada: This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and approved by the Continuing Medical Education Division, University of Saskatchewan for up to 5.0 credit hours.

The College of Family Physicians of Canada: This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the Continuing Medical Education Division, University of Saskatchewan up to 5.0 Mainpro+ credits. 

Pharmacy Professionals: Module 2 has been accredited by CPDPP for 5.5 CEUs for pharmacists and pharmacy technicians.

Paramedics: Module 2 has been accredited by the Saskatchewan College of Paramedics for 5.0 credits for practicing paramedics

Other Healthcare Professionals: Participation in this conference may be included as part of the continuing education and competence programs established by individual professional associations. 

 

AIMS-SK Scientific Planning Committee Members | Conflict of Interest Disclosures 

Dr, James Barton | COI FORM

Nicole Bootsman | COI FORM

Dr. Peter Butt  | COI FORM

Charity Evans | COI FORM

Mary Fraser | COI FORM

Danielle Larocque | COI FORM 

Dr. Morris Markentin | COI FORM

Dr. Karen Shaw | COI FORM

Dr. Werner Oberholzer | COI FORM 

Amy Wiebe | COI FORM

Dr. Andrew Yang | COI FORM

Event Information
Tammy Glynn, CME Event Coordinator
Email: tammy.glynn@usask.ca
cmelearning.usask.ca

• Facebook
• Twitter
• YouTube
• Instagram